SKI Market

Indian Indices

Nifty

22,570.35 167.95
(0.75%)

Sensex

74,339.44 486.50
( 0.66%)

Bank Nifty

48,494.95 305.95
( 0.63%)

Nifty IT

33,554.45 111.90
( 0.33%)

Global Indices

Nasdaq

15,712.75 16.11
(0.10%)

Dow Jones

38,460.92 -42.77
(-0.11%)

Hang Seng

17,284.54 83.27
(0.48%)

Nikkei 225

37,628.48 -831.60
(-2.16%)

Forex

USD-INR

83.31 -0.07
(-0.09%)

EUR-INR

88.96 0.13
(0.14%)

GBP-INR

103.28 0.27
(0.26%)

JPY-INR

0.54 0.00
(-0.11%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Vivimed Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532660

INE526G01021

7.4280394

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIVIMEDLAB

40.63

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)	Mar 2018 ( Cr)
Sales Turnover	176.83	218.37	210.05	276.61	251.81	261.39
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	176.83	218.37	210.05	276.61	251.81	261.39
Other Income	0.24	1.26	6.08	6.54	8.54	1.93
Stock Adjustments	-84.42	-0.49	-4.31	4.87	47.40	28.57
Total Income	92.65	219.14	211.82	288.02	307.75	291.89
EXPENDITURE :
Raw Materials	184.21	142.92	92.76	155.17	127.70	114.97
Power & Fuel Cost	8.73	7.55	9.02	8.99	8.92	10.83
Employee Cost	28.70	31.68	26.45	31.87	37.88	34.09
Other Manufacturing Expenses	20.40	17.65	18.98	16.08	21.30	20.11
Selling & Administrative Expenses	37.65	26.70	30.76	28.89	35.91	26.41
Miscellaneous Expenses	0.63	0.42	-0.07	7.75	0.01	5.21
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	280.31	226.92	177.91	248.74	231.72	211.62
Operating Profit	-187.67	-7.78	33.91	39.27	76.02	80.27
Interest	35.55	39.71	41.63	43.44	52.63	53.27
Gross Profit	-223.22	-47.49	-7.72	-4.17	23.39	27.00
Depreciation	106.91	17.45	15.80	16.57	18.26	18.14
Profit Before Tax	-330.13	-64.94	-23.52	-20.74	5.13	8.86
Tax	0.00	0.00	0.00	0.00	1.04	1.70
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-2.12	2.82	-0.23	-1.57	-2.09	-2.72
Reported Net Profit	-328.01	-67.75	-23.28	-19.17	6.19	9.87
Extraordinary Items	0.00	0.00	0.00	-6.87	0.00	0.00
Adjusted Net Profit	-328.01	-67.75	-23.28	-12.30	6.19	9.87
Adjustment below Net Profit	4.05	0.56	-6.14	-0.50	-0.97	-0.34
P & L Balance brought forward	207.54	274.73	304.15	323.82	318.61	312.36
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	3.28
P & L Balance carried down	-116.42	207.54	274.73	304.15	323.82	318.61
Dividend	0.00	0.00	0.00	0.00	0.00	3.30
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	20.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.40
Earnings Per Share-Unit Curr	-39.56	-8.17	-2.81	-2.31	0.75	1.20
Earnings Per Share(Adj)-Unit Curr	-39.56	-8.17	-2.81	-2.31	0.75	1.20
Book Value-Unit Curr	11.50	50.57	58.67	62.22	64.78	64.15
Book Value(Adj)-Unit Curr	11.50	50.57	58.67	62.22	64.78	64.15

22,570.35 167.95 (0.75%)

74,339.44 486.50 ( 0.66%)

48,494.95 305.95 ( 0.63%)

33,554.45 111.90 ( 0.33%)

15,712.75 16.11 (0.10%)

38,460.92 -42.77 (-0.11%)

17,284.54 83.27 (0.48%)

37,628.48 -831.60 (-2.16%)

83.31 -0.07 (-0.09%)

88.96 0.13 (0.14%)

103.28 0.27 (0.26%)

0.54 0.00 (-0.11%)